Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Neurocrine Biosciences, Inc. - Common Stock (NQ:NBIX)

110.78 -2.38 (-2.10%)
Streaming Delayed Price Updated: 2:08 PM EDT, Mar 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 441,476
Open 111.55
Bid (Size) 110.62 (1)
Ask (Size) 110.94 (1)
Prev. Close 113.16
Today's Range 109.00 - 112.60
52wk Range 105.17 - 157.98
Shares Outstanding 99,400,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX)—A High-Growth Stock Gearing Up for Its Next Upward Move.
Based on a technical and fundamental analysis of NASDAQ:NBIX we can say: NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX)—Positioned as a High-Growth Stock, Ready for a Potential Breakout. 
Via Chartmill
Neurocrine Biosciences: A Smart Biotech Bet With Blockbuster Potential
Via The Motley Fool

Performance

YTD
-19.6%
-19.6%
1 Month
-6.7%
-6.7%
3 Month
-19.2%
-19.2%
6 Month
-3.9%
-3.9%
1 Year
-21.6%
-21.6%

More News

Read More
Deep Dive Into Neurocrine Biosciences Stock: Analyst Perspectives (14 Ratings)
Via Benzinga
Despite its growth, NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) remains within the realm of affordability.
Via Chartmill
NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Via Chartmill
Assessing Neurocrine Biosciences: Insights From 15 Financial Analysts
Via Benzinga
Why Neurocrine Biosciences Stock Sank Today
Via The Motley Fool
Why the quality investor may take a look at NASDAQ:NBIX.
Via Chartmill
NASDAQ:NBIX is showing decent growth, but is still valued reasonably.
Via Chartmill
Estee Lauder, Moderna And PayPal Are Among Top 10 Large Cap Losers Last Week (Feb 3-Feb 7): Are The Others In Your Portfolio?
Via Benzinga
Why Is Neurocrine Biosciences Stock Trading Lower On Friday?
Via Benzinga
Neurocrine Biosciences Reports Mixed Q4
Via The Motley Fool
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Earnings Summary: Neurocrine Biosciences Q4
Via Benzinga
Earnings Scheduled For February 6, 2025
Via Benzinga
Neurocrine Biosciences Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
Via Benzinga
Neurocrine Crumbles On Lackluster Guidance For Its Bread-And-Butter Drug
Via Investor's Business Daily
Looking for growth without the hefty price tag? Consider NASDAQ:NBIX.
Via Chartmill
NASDAQ:NBIX is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Via Chartmill
Neurocrine Obtains Exclusive Rights For Depression Drug, Takeda Reacquires Japan Rights
Via Benzinga
NASDAQ:NBIX stands out as a growth opportunity that won't break the bank.
Via Chartmill
Why NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) Deserves Consideration as a Quality Investment.
Via Chartmill
Exploring the Growth Potential of NASDAQ:NBIX as It Nears a Breakout.
Via Chartmill
NASDAQ:NBIX: good value for what you're paying.
Via Chartmill
Neurocrine Biosciences Stock Sees RS Rating Upgrade
Via Investor's Business Daily

Frequently Asked Questions

Is Neurocrine Biosciences, Inc. - Common Stock publicly traded?
Yes, Neurocrine Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Neurocrine Biosciences, Inc. - Common Stock trade on?
Neurocrine Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Neurocrine Biosciences, Inc. - Common Stock?
The ticker symbol for Neurocrine Biosciences, Inc. - Common Stock is NBIX on the Nasdaq Stock Market
What is the current price of Neurocrine Biosciences, Inc. - Common Stock?
The current price of Neurocrine Biosciences, Inc. - Common Stock is 110.78
When was Neurocrine Biosciences, Inc. - Common Stock last traded?
The last trade of Neurocrine Biosciences, Inc. - Common Stock was at 03/31/25 02:08 PM ET
What is the market capitalization of Neurocrine Biosciences, Inc. - Common Stock?
The market capitalization of Neurocrine Biosciences, Inc. - Common Stock is 11.01B
How many shares of Neurocrine Biosciences, Inc. - Common Stock are outstanding?
Neurocrine Biosciences, Inc. - Common Stock has 11B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.